Aquestive therapeutics to present positive data from pharmacokinetic studies for aqst-109 (epinephrine sublingual film) at american academy of allergy, asthma, and immunology (acaai) annual scientific meeting

Warren, n.j., nov. 09, 2022 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst), a pharmaceutical company advancing current standards of care to solve patients' problems through simplifying complex delivery methods, will present three abstracts recapping positive data from its completed pharmacokinetic studies of aqst-109 (epinephrine sublingual film) at the american college of allergy asthma and immunology (acaai) annual scientific meeting, which will be held from november 10-14, in louisville, kentucky.
AQST Ratings Summary
AQST Quant Ranking